Health Archives - Barbados Today
Blue House
As people across the globe marked World Autism Awareness Day today, Barbadians were not left out. Blue was the hue of the day as individuals wore the colour designated for autism.
As people across the globe marked World Autism Awareness Day today, Barbadians were not left out. Blue was the hue of the day as individuals wore the colour designated for autism. This evening, members of the Autism Association of Barbados and representatives of both the House of Assembly and Senate converged at the Parliament Buildings which were lit up in the colour which is also associated with calmness and acceptance. Family members Nadia, Aidan, and Robert Simmons were among those in attendance for the lighting up.
(Photo by Jeffrey Bishop)
The post Blue House appeared first on Barbados Today.
1 year 2 months ago
Health, Local News
The importance of choosing natural body care
EATING A healthy diet, drinking water regularly, exercising, and taking care of your mental health are all examples of the everyday actions we take to care for our bodies. However, why do we allow our bodies to absorb many chemicals by applying...
EATING A healthy diet, drinking water regularly, exercising, and taking care of your mental health are all examples of the everyday actions we take to care for our bodies. However, why do we allow our bodies to absorb many chemicals by applying...
1 year 2 months ago
Nurturing healthy skin
THE SKIN is the largest organ in the body and covers the body’s entire external surface. It is made up of three layers – the epidermis, dermis, and the hypodermis – all three of which vary significantly in their anatomy and function. The skin’s...
THE SKIN is the largest organ in the body and covers the body’s entire external surface. It is made up of three layers – the epidermis, dermis, and the hypodermis – all three of which vary significantly in their anatomy and function. The skin’s...
1 year 2 months ago
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Exercise-associated secondary amenorrhea in physically active women linked to cardiovascular disease: JAHA
Canada: A recent systematic review and meta-analysis has shed light on the impact of secondary amenorrhea on cardiovascular disease (CVD) risk in physically active women. The findings were published online in the Journal of the American Heart Association.
Observational studies linked secondary amenorrhea to several cardiovascular (CV) risk factors in physically active women. "Estrogen deficiency resulting from exercise-associated secondary amenorrhea in physically active women may affect CV physiology and certain CVD risk factors," the researchers wrote. However, they noted that research in the area is observational, and findings should be interpreted cautiously.They add, "As exercise-associated amenorrhea is reversible and primary prevention of cardiovascular disease is important for public health, it may be important to treat secondary amenorrhea and restore estrogen levels. Exercise-associated secondary amenorrhea leads to estrogen deficiency, which may result in dysfunction in estrogen's normal cardioprotective pathways. Estrogen may be essential in a woman's endothelial adaptations to exercise. Nicole L. Tegg, Faculty of Nursing University of Alberta Edmonton Alberta Canada, and colleagues aimed to assess the association between secondary amenorrhea in physically active women and CVD risk. For this purpose, the researchers performed a literature search in January 2023 and updated in August 2023 of the online databases from inception to present with no date or language limitations. Citation chaining was done to screen for additional studies. Eight sources were searched for gray literature.The review included studies that compared physically active women with amenorrhea to physically active women with eumenorrhea aged 18 to 35 years with evidence of cardiovascular disease, alterations to cardiovascular physiology, or CVD risks. Eighteen observational studies from three countries were included. The quality of evidence was good overall. "Physically active women with secondary amenorrhea had significantly lower estradiol, resting heart rate, flow-mediated dilation, systolic blood pressure, and diastolic blood pressure and higher total cholesterol, high-density lipoprotein, triglycerides, and low-density lipoprotein cholesterol," the researchers reported. In conclusion, the systematic review and meta-analysis found that functional hypothalamic amenorrhea may obviate CV benefits of exercise and may adversely impact CV physiology and certain CVD risk factors, including, endothelial function and lipid profiles. The findings highlight a need to further investigate the long-term CV consequences of hypoestrogenemia. Given the hormonal profiles of athletes with amenorrhea (AAs) and the evidence suggesting AAs may demonstrate increased CVD risk factors, determining the causative factor of amenorrhea is important so that appropriate interventions may be explored to restore menses and thereby, estrogen levels. .Finally, increasing awareness of the CV health consequences linked with energy deficiency is of paramount importance."There is a need for high-quality, large‐scale longitudinal studies to investigate the underlying relationships between secondary amenorrhea and the development of cardiovascular diseases and to increase the understanding of the clinical relevance of findings in this area," the researchers wrote.Reference:Tegg NL, Myburgh C, O'Donnell E, Kennedy M, Norris CM. Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2024 Mar 18:e033154. doi: 10.1161/JAHA.123.033154. Epub ahead of print. PMID: 38497482.
1 year 2 months ago
Cardiology-CTVS,Medicine,Obstetrics and Gynaecology,Cardiology & CTVS News,Medicine News,Obstetrics and Gynaecology News,Top Medical News,Latest Medical News
World Autism Awareness Day 2024: From surviving to thriving
“World Autism Awareness Day serves as a powerful reminder of the importance of understanding, acceptance, and inclusion for individuals with ASD”
View the full post World Autism Awareness Day 2024: From surviving to thriving on NOW Grenada.
“World Autism Awareness Day serves as a powerful reminder of the importance of understanding, acceptance, and inclusion for individuals with ASD”
View the full post World Autism Awareness Day 2024: From surviving to thriving on NOW Grenada.
1 year 2 months ago
Health, PRESS RELEASE, ASD, autism spectrum disorder, ministry of education, sien, special and inclusive education needs unit, world autism awareness day
Steps to prevent further spread of chickenpox at Mt Gay Hospital
“The ministries of Health, Mental Health, Wellness, and Religious Affairs said if no new cases of chickenpox emerge, visits to the Mt Gay Hospital will resume on Saturday, 6 April 2024”
View the full post Steps to prevent further spread of chickenpox at Mt Gay Hospital on NOW Grenada.
1 year 2 months ago
Community, Health, PRESS RELEASE, chickenpox, coronavirus, COVID-19, gis, government information service, Mental Health, mt gay hospital, religious affairs, wellness
Latin America experiences worst dengue fever outbreak on record | DW News - DW News
- Latin America experiences worst dengue fever outbreak on record | DW News DW News
- Opinion | I'm a Doctor. Dengue Fever Took Even Me by Surprise on Vacation. The New York Times
- Dengue and severe dengue World Health Organization (WHO)
- Puerto Rico declares public health emergency as dengue cases surge CNN
- Puerto Rico Declares Epidemic Over Dengue - Videos from The Weather Channel The Weather Channel
1 year 2 months ago
Natural and refined sugars and their effects on the body
“Limit your consumption of foods that contain refined or processed sugars such as sodas and sweetened beverages and juices, cakes and cookies, candies and confectionary”
View the full post Natural and refined sugars and their effects on the body on NOW Grenada.
1 year 2 months ago
Health, PRESS RELEASE, cholesterol, gfnc, grenada food and nutrition council, heart disease, high blood pressure, insulin resistance, Obesity, sugar, type 2 diabetes
PAHO/WHO | Pan American Health Organization
Países de las Américas reportan avances en el envejecimiento saludable
Countries of the Americas report progress towards healthy aging
Cristina Mitchell
2 Apr 2024
Countries of the Americas report progress towards healthy aging
Cristina Mitchell
2 Apr 2024
1 year 2 months ago
STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more
Rise and shine, everyone, another busy day is on the way. We can tell because our inbox is overflowing with correspondence and interesting ideas, a sure sign that we will be fully engaged for hours to come. To cope, yes, we are firing up the trusty coffee kettle and brewing some cups of stimulation. Our choice today is blueberry muffin. And yes, you are invited to join us.
Meanwhile, here is the latest menu of tidbits for you to digest. We hope you have smashing day and conquer the world. And do keep in touch. We enjoy the missives very much. …
Top European prosecutors are investigating allegations of criminal wrongdoing in connection with vaccine negotiations between European Commission President Ursula von der Leyen and the Pfizer chief executive officer, Politico reports. Investigators from the European Public Prosecutor’s Office have in recent months taken over from Belgian prosecutors investigating von der Leyen over “interference in public functions, destruction of SMS, corruption and conflict of interest.” No one has yet been charged in connection with the case. The probe was originally opened by Belgian judicial authorities in early 2023 after a criminal complaint was lodged by a local lobbyist.
The net prices that health plans paid for medicines — after subtracting rebates, discounts, and fees — fell by 2.8% in last year’s fourth quarter, STAT writes, adding this is the largest decline ever measured by SSR Health, a research firm that tracks the pharmaceutical industry and its pricing trends. A key reason for the big drop — which dwarfed the 0.4% decline seen at the same time a year earlier — was pricing pressure on the Humira treatment for rheumatoid arthritis and psoriasis from biosimilar versions of the medicine. The Humira net price fell to roughly $29,800 at the end of last year from $48,000 at the end of 2022, a nearly 38% drop.
1 year 2 months ago
Pharma, Pharmalot, pharmalittle, STAT+
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Recognizing the Early Signs of Kidney Problems and When to Seek Medical Advice - Dr Deepashree G A
Approximately 850 million people are affected by chronic kidney disease (CKD) globally. People of every age and race are affected, and most don’t know it. While there are numerous physical signs of renal disease, they are sometimes mistaken for symptoms of other illnesses.
Furthermore, people with kidney disease typically do not exhibit any symptoms until the very end, either when their kidneys are failing or when their urine contains a significant amount of protein. This contributes to the fact that only 10% of patients with chronic renal disease are aware of their condition.
In India, CKD affects nearly 800 people out of every one million individuals, with ESRD rates varying between 150 and 200 per million population. About one out of ten Indians has Chronic Kidney Disease (CKD), and more than a hundred thousand cases of kidney failure are reported annually.
Based on global statistics, kidney disease is the sixth fastest-growing cause of death, leading to an estimated 1.7 million deaths as a result of acute kidney injury globally. Over 7.8 million people in India suffer from some form of chronic kidney problems.
If you have high blood pressure, diabetes, a family history of kidney failure, or are over 60, you should get annual kidney disease testing. Additionally, look for early signs of kidney problems and inform your healthcare provider of any symptoms you are experiencing.
When To See A Doctor
1. You feel the need to Urinate more Often
Frequent urination, particularly at night, may indicate a renal problem. Damage to the kidney's filters can increase the need to urinate. In some cases, this symptom can indicate an enlarged prostate in men or a urinary tract infection.
2. You see Blood in your Urine
When the kidneys work properly, blood cells remain within the body to filter wastes from the blood and produce urine. However, if the kidney's filters fail, blood cells may begin to "leak" into urine. Blood in the urine can indicate renal disease, tumours, kidney stones, infections, and kidney disease.
3. Your Urine is Foamy
If you notice a lot of bubbles in your urine, especially if they stick around after several flushes, it could mean there's protein in there. This foam may resemble the froth produced when scrambling eggs, as albumin, the primary protein found in urine, is similar to the protein found in eggs.
4. You're noticing Persistent Swelling around your Eyes
The presence of protein in the urine is an early indicator of kidney filter damage, which permits protein leakage into the urine. Swelling around the eyes may occur because the kidneys expel a significant amount of protein instead of retaining it in the body.
5. Your Ankles and Feet are Swollen
Ankle and foot swelling may result from salt retention brought on by reduced renal function. Additionally, chronic leg vein issues, liver illness, and heart disease can all be indicated by swelling in the lower legs.
6. You have high Blood Pressure
The kidneys regulate blood pressure by secreting hormones constricting blood vessels and maintaining fluid balance.
Therefore, hypertension (high blood pressure) can occur when the kidneys are damaged, and especially young people should rule out all secondary causes of high blood pressure and should always have a meticulous follow-up
7. You are suffering from Shortness of Breath
Kidney disease can cause fluid buildup in the lungs, resulting in breathing difficulties or shortness of breath.
8. You’re More Tired, have less Energy or are having Trouble Concentrating.
A significant decline in kidney function can result in the accumulation of toxins and impurities in the bloodstream. This buildup can manifest as fatigue, weakness, and difficulty concentrating. Anaemia, another complication of kidney disease, can further contribute to feelings of weakness and fatigue.
9. You’re having Trouble Sleeping
When kidney function is compromised, and filtration is inadequate, toxins remain in the bloodstream instead of being eliminated from the body through urine. This can make it difficult to sleep.
Furthermore, there is a correlation between obesity and chronic kidney disease, and individuals with chronic kidney disease are more prone to experiencing sleep apnea than the general population.
10. You have Dry and Itchy Skin
Healthy kidneys do many important jobs. They work to retain the proper balance of minerals in your blood, eliminate waste and excess fluid from your body, aid in producing red blood cells, and support healthy bones. The kidneys' inability to maintain this balance can result in mineral and bone disease, which is frequently associated with severe renal disease and manifested as dry and itchy skin.
11. You have a Poor Appetite
While this symptom is nonspecific, it could be attributed to the accumulation of toxins stemming from diminished kidney function.
12. Your Muscles are Cramping
Electrolyte imbalances can result from impaired kidney function. Muscle cramping, for example, could be caused by poor phosphorus regulation and low calcium levels.
Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.
1 year 2 months ago
Health Dialogues
STAT+: Net prices for medicines fell considerably in 2023’s last quarter, mostly thanks to Humira biosimilars
The net prices that health plans paid for medicines — after subtracting rebates, discounts, and fees — fell by 2.8% in last year’s fourth quarter, the largest decline ever measured by SSR Health, a research firm that tracks the pharmaceutical industry and its pricing trends.
A key reason for the big drop — which dwarfed the 0.4% decline seen at the same time a year earlier — was pricing pressure on the Humira treatment for rheumatoid arthritis and psoriasis. Over the past year, nine biosimilar versions of the medicine were launched by other companies seeking favorable placement on formularies, the lists of drugs for which health insurance coverage is available.
As these companies battled to win placement, the Humira net price fell to roughly $29,800 at the end of last year from $48,000 at the end of 2022, a nearly 38% drop, the SSR analysis found. In fact, the entire category of rheumatoid arthritis medicines saw a 30% decline in annual net pricing, the largest such drop among all type of drugs. Meanwhile, net prices for psoriasis treatments fell nearly 10%.
1 year 2 months ago
Pharma, Pharmalot
Rare human case of highly contagious bird flu confirmed in Texas
The Centers for Disease Control and Prevention announced Monday that a person in Texas has tested positive for highly pathogenic avian influenza, otherwise known as H5N1 bird flu.
The Centers for Disease Control and Prevention announced Monday that a person in Texas has tested positive for highly pathogenic avian influenza, otherwise known as H5N1 bird flu.
"This person had exposure to dairy cattle in Texas presumed to be infected with HPAI A(H5N1) viruses. The patient reported eye redness (consistent with conjunctivitis), as their only symptom, and is recovering," the CDC said in a statement. "The patient was told to isolate and is being treated with an antiviral drug for flu."
The CDC said this is the second case of a human testing positive for H5N1 in the United States, after a previous case was observed in Colorado in 2022.
"This infection does not change the H5N1 bird flu human health risk assessment for the U.S. general public, which CDC considers to be low," it added. "However, people with close or prolonged, unprotected exposures to infected birds or other animals (including livestock), or to environments contaminated by infected birds or other animals, are at greater risk of infection."
US TUBERCULOSIS CASES IN 2023 WERE AT HIGHEST LEVEL IN A DECADE, CDC SAYS
Last week, dairy cows in Texas and Kansas were reported to be infected with bird flu – and federal agriculture officials later confirmed infections in a Michigan dairy herd that had recently received cows from Texas.
This bird flu was first identified as a threat to people during a 1997 outbreak in Hong Kong, according to the Associated Press. More than 460 people have died in the past two decades from bird flu infections, the World Health Organization says.
PUERTO RICO HEALTH OFFICIALS DECLARE DENGUE FEVER A PUBLIC HEALTH EMERGENCY
Texas officials did not identify the newly infected person, nor release any details about what brought them in contact with the cows.
The CDC said it is "working with state health departments to continue to monitor workers who may have been in contact with infected or potentially infected birds/animals and test those people who develop symptoms."
"Human illnesses with H5N1 bird flu have ranged from mild (e.g., eye infection, upper respiratory symptoms) to severe illness (e.g., pneumonia) that have resulted in death in other countries," the CDC also said.
The Associated Press contributed to this report.
1 year 2 months ago
infectious-disease, texas, Health
Adultos mayores, agotados por tener que organizar tanta atención médica
En enero, Susanne Gilliam, de 67 años, estaba yendo a recoger el correo afuera de su casa cuando se cayó al resbalar sobre una capa de hielo negro.
Sintió una punzada de dolor en la rodilla y el tobillo de la pierna izquierda. Después de llamar a su marido por teléfono, logró regresar a su casa con dificultad.
En enero, Susanne Gilliam, de 67 años, estaba yendo a recoger el correo afuera de su casa cuando se cayó al resbalar sobre una capa de hielo negro.
Sintió una punzada de dolor en la rodilla y el tobillo de la pierna izquierda. Después de llamar a su marido por teléfono, logró regresar a su casa con dificultad.
Y así comenzó el vaivén interminable que tantas personas enfrentan cuando tienen que navegar el desorganizado sistema de salud de Estados Unidos.
El cirujano ortopédico de Gilliam, que la había tratado antes por problemas en la misma rodilla, la vio esa tarde pero le aclaró: “Yo no me ocupo de tobillos”.
La derivó a un especialista en tobillos que ordenó nuevas radiografías y una resonancia magnética. Gilliam pidió hacerse las pruebas en un hospital cerca de su casa en Sudbury, Massachusetts, que le resultaba más conveniente. Pero cuando llamó para pedir una cita, el hospital no tenía la orden del doctor, que finalmente llegó después de varias llamadas más.
Coordinar la atención que necesita para recuperarse, incluyendo sesiones de fisioterapia, se convirtió en un trabajo de medio tiempo para Gilliam. (Los terapeutas trabajan solo en una parte del cuerpo por sesión, y por lo tanto Gilliam requiere visitas separadas para su rodilla y su tobillo, varias veces a la semana).
“El peso de organizar todo lo que necesito es enorme”, dijo Gilliam. “Te queda una sensación de agotamiento físico y mental”.
En algunos casos, las deficiencias del sistema de salud son el precio que se paga por avances extraordinarios en el campo de la medicina. Pero también ponen en evidencia las incoherencias entre las capacidades de los adultos mayores y las demandas del sistema.
“La buena noticia es que sabemos mucho más y podemos hacer mucho más por las personas con distintas afecciones”, dijo Thomas H. Lee, director médico de Press Ganey, una consultoría que hace seguimiento de las experiencias de los pacientes con el sistema de salud. “La mala noticia es que el sistema se ha vuelto tremendamente complejo”.
Esto se agrava por las múltiples guías para tratar afecciones, la super especialización médica, y los incentivos financieros que hacen que los pacientes reciban cada vez más atención, dijo Ishani Ganguli, profesora asociada en la Escuela de Medicina de Harvard.
“No es raro que pacientes mayores tengan tres o más cardiólogos que les programan citas y pruebas regulares”, dijo. Si alguien tiene varios problemas de salud (por ejemplo, enfermedades cardíacas, diabetes y glaucoma), las interacciones con el sistema se multiplican.
Ganguli es la autora de un nuevo estudio que muestra que los pacientes de Medicare dedican aproximadamente tres semanas al año a hacerse pruebas médicas, ver a doctores, someterse a tratamientos o procedimientos médicos, buscar atención en salas de emergencia o pasar tiempo en el hospital o en centros de rehabilitación. (Los datos son de 2019, antes de la pandemia de covid, que alteró los patrones de atención médica. Cada servicio recibido se contó como un día de contacto con el sistema de salud).
El estudio determinó que poco más de 1 de cada 10 personas mayores, incluyendo las que se estaban haciendo controles o recuperándose de enfermedades graves, pasaban más tiempo recibiendo atención médica: al menos 50 días al año.
“Hay aspectos de esto que son muy beneficiosos y valiosos para las personas, pero hay otros que son menos esenciales”, dijo Ganguli. “No hablamos lo suficiente sobre lo que les pedimos a los adultos mayores que hagan, y si tiene sentido”.
Victor Montori, profesor de medicina de la Clínica Mayo en Rochester, Minnesota, lleva muchos años advirtiendo sobre lo que llama la “carga de tratamiento” que enfrentan los pacientes.
Esto incluye el tiempo que dedican a recibir atención médica, programar citas, encontrar transporte para las visitas médicas, obtener y tomar medicamentos, comunicarse con las aseguradoras, pagar facturas médicas, monitorear su salud en casa y seguir consejos como cambios en la dieta.
Hace cuatro años, en un artículo titulado “¿Se siente mi paciente agobiado?”, Montori y sus colegas descubrieron que el 40% de los pacientes con enfermedades crónicas como asma, diabetes y trastornos neurológicos “sentían que su carga de tratamiento era insostenible”.
Cuando la carga de tratamiento es excesiva, las personas dejan de seguir las recomendaciones médicas y dicen que su calidad de vida empeora, según los investigadores. Los adultos mayores con múltiples afecciones médicas y bajo nivel de educación son especialmente vulnerables, ya que experimentan inseguridad económica y aislamiento social.
El uso cada vez más frecuente de sistemas telefónicos digitales y portales electrónicos para pacientes en los consultorios y la falta de tiempo por parte de los doctores profundizan las barreras. “Cada vez es más difícil para los pacientes acceder a doctores que puedan pasar tiempo con ellos, para ayudarlos a resolver problemas y responder sus preguntas”, dijo Montori.
Mientras tanto, los médicos rara vez preguntan a los pacientes sobre su capacidad para realizar las tareas que se les pide. “A menudo tenemos poca idea de qué tan compleja es la vida de nuestros pacientes”, escribieron médicos en un informe de 2022 sobre cómo reducir la carga de tratamiento.
Un ejemplo es lo que vivieron Jean Hartnett, de 53 años de Omaha, Nebraska, y sus ocho hermanos después que su madre de 88 años sufriera un derrame cerebral en febrero de 2021, mientras hacían compras en Walmart.
En ese momento, su madre estaba cuidando al padre de Hartnett, quien sufría de una enfermedad renal y necesitaba ayuda con las tareas diarias, como ducharse o ir al baño.
Durante el año posterior al derrame cerebral, los padres de Hartnett, ambos trabajadores agrícolas extremadamente independientes que vivían en Hubbard, Nebraska, sufrieron varios achaques y las crisis médicas se volvieron comunes.
Cuando un médico cambiaba el plan de atención de su mamá o su papá, eran necesarios nuevos medicamentos, suministros y equipos médicos, y programar nuevas sesiones de terapia ocupacional, física y del habla.
Ninguno de los padres podía quedarse solo si el otro necesitaba atención médica.
“No era inusual para mí estar llevando a uno de mis padres a su casa después del hospital o de la visita al médico y pasar una ambulancia o un familiar transportando al otro al doctor”, explicó Hartnett. “Se necesitaba muchísima coordinación”.
Hartnett se mudó a la casa de sus padres durante las últimas seis semanas de vida de su padre, cuando los médicos decidieron que estaba demasiado débil como para someterse a diálisis. Falleció en marzo de 2022. Su madre murió meses después, en julio.
Entonces, ¿qué pueden hacer los adultos mayores y sus cuidadores y familiares para aliviar la carga de la atención médica?
Para empezar, es importante sincerarse con el médico si el plan de tratamiento que recomienda no resulta factible, y explicarle por qué, dijo Elizabeth Rogers, profesora asistente de medicina interna en la Escuela de Medicina de la Universidad de Minnesota.
Recomendó preguntar sobre cuáles intervenciones serían las más importantes para mantenerse saludable y cuáles podrían ser prescindibles.
Los médicos pueden ajustar los planes, suspender los medicamentos que no producen beneficios significativos y programar visitas virtuales, en caso de que las personas puedan manejar la tecnología necesaria (muchos adultos mayores no pueden).
Pregunte también si un asistente de pacientes (también llamados navegadores) puede ayudarle a programar varias citas y exámenes en el mismo día, para minimizar la carga de ir y venir de los centros médicos. Estos profesionales también pueden ayudarlo a conectarse con recursos comunitarios, como servicios de transporte. (La mayoría de los centros médicos tienen personal de este tipo, pero los consultorios médicos no).
Si no entiende cómo hacer lo que su médico pide, pregunte: ¿Qué implicaría esto de mi parte? ¿Cuánto tiempo llevaría? ¿Qué necesitaré? Y pida materiales escritos, como guías de autocontrol del asma o la diabetes, que puedan ayudarle a comprender mejor los requisitos.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.
USE OUR CONTENT
This story can be republished for free (details).
1 year 2 months ago
Aging, Health Care Costs, Health Industry, Insurance, Medicare, Navigating Aging, Noticias En Español, Massachusetts, Nebraska
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
CDSCO Drug Alert: 58 Drug Samples Including Alkems's Pyricool 500, Sun Pharma's Zole F Flagged
New Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Standard Control Organisation (CDSCO) has flagged 58 medicine batches for failing to qualify for a random sample test for February 2023, while 2 drug samples have been declared as suprious.
These drugs include Acepik - P (Aceclofenac and Paracetamol Tablets) manufactured by Nexkem Biotech, Amoxycillin Oral Suspension I.P. (Medmoxil 125) manufactured by Laborate Pharmaceuticals, Calcium Carbonate and Vitamin D3 Tablets IP (Calcigiant 500 Tablets) manufactured by Nutra Life Healthcare, Ofloxacin manufactured by Concept Pharmaceutical, Calcium and Vitamin D3 Tablets manufactured by Hanuchem Laboratories, Serratiopeptidase Tablets manufactured by Arnav Research Laboratories.
Furthermore, the list contains, Paracetamol Tablets IP 500 mg (Pyricool 500) manufactured by Alkem Health Science, a unit of Alkem Laboratories Limited, Deferasirox manufactured by Glenmark Lifesciences, Miconazole Nitrate and Fluocinolone Acetonide Ointment (Zole - F) manufactured by Sun Pharmaceuticals and others.
In addition to the above, Telmisartan Tablets 40 mg and Amlodipine 5 mg Tablets IP (Telma AM) belonging batch no 05230355 and Telmisartan Tablets I.P. 40 mg (Telma 40), belonging batch no I8220890 are declared spurious as the actual manufacturer, Glenmark Pharmaceutical (as per label claim) has informed that the impugned batches of the products have not been manufactured by them and that it is a spurious drug.
"Thus, the products are purported to be spurious, however, the same is subject to outcome of further investigation." the actual manufacturer, Glenmark Pharmaceutical added.
The list came after analysis and tests were conducted by the CDSCO, Drugs Control Departments on 1167 samples. Out of this, 1018 samples were found of standard quality while 58 were declared Not of Standard Quality (NSQ).
A few reasons why the drug samples tested failed were the failure of the assay, failure of the dissolution test, failure of the disintegration test, failure of Uniformity of Dispersion, and the presence of water content and particulate matter etc.
The samples collected were tested in CDL Kolkata, CDTL Hyderabad, CDTL Mumbai, RDTL Chandigarh and RDTL Guwahati.
List of Drugs, Medical Devices, Vaccines and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of February– 2024.
Total no. of samples received
- 676
Total number of samples tested
- 1167
Total number of samples declared as of Standard Quality
- 1018
Total number of samples declared as Not of Standard Quality - 58
Total number of samples declared as Spurious
- 02
Total number of samples declared as Misbranded
- NIL
S.N
o
Name of Drugs/medical device/cosmetics
Batch No.
Date of Manufactu re
Date of Expiry
Manufactured By
Reason for failure
Drawn By (From
state/CDS CO Zone)
From (Name of Laboratory)
1
Acepik - P (Aceclofenac and Paracetamol Tablets)
NKT230962A
05/2023
04/2025
Nexkem Biotech Pvt. Ltd., Plot No. 64, HPSIDC, Industrial Area, Baddi, Distt. Solan (H.P.) - 173
205.
Disintegration
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
2
Amoxycillin Oral Suspension I.P. (Medmoxil 125)
XMSD-001
03/2023
08/2024
Laborate Pharmaceuticals India Ltd., 51, Indl, Area, Paonta Sahib
(H.P.)
Stability
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
3
Calcium Carbonate and Vitamin D3 Tablets IP (Calcigiant 500 Tablets)
NLT-17023
05/2023
04/2025
Nutra Life Healthcare Pvt. Ltd., Plot No. 44-45, Shiv Ganga Industrial Estate,
Lakeshwari, Bhagwanpur, Roorkee, Distt.
Haridwar, Uttarakhand
Assay of Vitamin D3
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
4
Ofloxacin Dispersible Tablets IP 100 mg (Oflab 100 DT)
C21O062001
05/2022
04/2024
Concept Pharmaceuticals Ltd., A-28/3 MIDC,
Chikalthana, Aurangabad-431006
Uniformity of Dispersion
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
5
Calcium and Vitamin D3 Tablets IP (MAHACAL -500)
KSWAC014
05/2023
04/2025
Hanuchem Laboratories, Plot No. 16-17, Sector - 5, Indl. Area, Parwanoo, Dist.
Solan 173 220 (H.P.)
Assay of Vitamin D3
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
6
Serratiopeptidase Tablets (Serrizym Tablet)
AT035M
07/2023
06/2025
Arnav Research Laboratories, 435,
G.I.D.C. 2, Dediyasan, Mehsana,
Gujarat 384002
Assay
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
7
Montelukast Sodium and Levocetirizine Hydrochloride Tablet IP (XL-Mont)
TXL012007
11/2022
10/2024
DWD
Pharmaceuticals Ltd., 308/5, Village & Post: Poicha (Rania), Tal Savli, Dist.
Vadodara 391780, Gujarat, India
Desription
Drugs Inspector, Ranchi, Jharkhand
Central Drugs Laboratory, Kolkata
8
Propofol Injection IP 500 mg/50 ml
(Hyprovan 500 Injection)
L3352301A
06/2023
05/2025
Protech Telelinks, Mauza Ogli, Suketi Road, Kala Amb. Dist. Sirmour - 173030 (H.P.)
Assay of Propofol
Drugs Inspector, Bilaspur, Himachal Pradesh
Central Drugs Laboratory, Kolkata
9
Heparin Sodium Injection IP 25000 IU/5ml
22HE16
10/2022
09/2024
SAI Parenterals Limited, D1 & D4, Survey No. 280, Phase-V, IDA, Jeedimetla,
Hyderabad 500 055, Telangana, India
Description, Extractable Volume, Particulate Matter and Assay
Drugs Inspector, Bikaner, Rajasthan
Central Drugs Laboratory, Kolkata
10
Metformin HCl (SR) with Glimepiride & Voglibose Tablets (Metaglim-V2)
T-230859
08/2023
07/2025
Vilin Bio Med Ltd., Unit-II, Khasra No.
85, Madhopur Hazarathpur, Roorkee -247667,
Uttarakhand
Assay of Glimepiride
CDSCO,
Rishikesh
Central Drugs Laboratory, Kolkata
11
Clarithromycin Tablets IP 250 mg
OT-231393
10/2023
09/2025
Orchid Bio-Tech Limited, 65, Peerpura-Delhi Highway, Roorkee- 247667 (U.K.)
Dissolution
CDSCO,
Rishikesh
Central Drugs Laboratory, Kolkata
12
Rabeprazole Sodium & Domperidone Capsules (Deep SR Capsules)
OC-23349
11/2023
10/2025
Orchid Bio-Tech Limited, 65, Peerpura-Delhi
Highway, Roorkee - 247667 (U.K.)
Dissolution of Rabeprazole & Domperidone
CDSCO,
Rishikesh
Central Drugs Laboratory, Kolkata
13
Glimepiride & Meftormin Hydrochloride Prolonged Release Tablets IP (Glimsid-
2MF)
T-231020
10/2023
09/2025
Vilin Bio Med Ltd., Unit-II, Khasra No.85, Madhopur, Hazarathpur, Roorkee-247667,
Uttarakhand.
Dissolution & Assay of Glimepiride
CDSCO,
Rishikesh
Central Drugs Laboratory, Kolkata
14
Liquid Formaldehyde 40% w/v (Formallin)
FS-228A
08/2022
07/2025
Pharm Asia Drug, 20-21, Panchal Compound, Survey
No. 78/1, PH No. 17,
New 45, Gram Lasudia Mori, Indore
- 452 010 (M.P.)
Methyl Alcohol & Assay of Formaldehyde 40%w/v
CDSCO,
North Zone
Central Drugs Laboratory, Kolkata
15
Piroxicam Capsules IP (Piroxicam-20)
KCC-03
11/2023
10/2025
SGS Pharmaceutical (P) Ltd., E-13/1,
Kavi Nagar Indl. Area, Sector - 17, Ghaziabad 201002
(U.P.)
Water content
CDSCO,
North Zone
Central Drugs Laboratory, Kolkata
16
Hydrogen Peroxide Topical Solution IP 6% w/v (20 Volume)
HP23-021
02/2023
01/2025
Pharm Asia Drug, 20-21, Panchal Compound, Survey
No. 78/1, PH No. 17,
New 45, Gram Lasudia Mori, Indore
- 452 010 (M.P.)
Identification, Acidity, Non-volatile matter and Assay
(Spurious)
CDSCO,
North Zone
Central Drugs Laboratory, Kolkata
17
L-Asparaginase 10000 IU (L-ASGEN)
BASL2205Y A
03/2022
02/2024
Beta Drugs Ltd., Kharuni Lodhimajra Road, Vill. Nandpur, Baddi, Dist. Solan, Himachal Pradesh
173205
Particulate Matter (subvisible)
O/o. The Drugs Inspector, Cuttack, Odisha.
Central Drugs Laboratory, Kolkata
18
Amikacin Injection IP 500 mg (Amikatas 500 mg)
RV3044
08/2023
07/2025
Ronam Healthcare Pvt. Ltd. Village- Kalujhanda, Tehsil- Baddi, Distt. Slolan (H.P.) 174103
Description & Particulate Matter
O/o. The Drugs Inspector, Cuttack, Odisha.
Central Drugs Laboratory, Kolkata
19
Neostigmine Injection IP 0.5 mg/ml
V23034
01/02/2023
31/01/2025
Vital Healthcare Pvt. Ltd., Plot No. H10 and H10/1, MIDC Satpur, Nashik.
pH and Assay of Neostigmine
CDSCO,
West Zone, Mumbai
Central Drugs Laboratory, Kolkata
20
Tranexamic Acid Injection I.P. (Tranexica)
SAI-14764
03/2022
02/2024
Sunvet Healthcare, Vill. Shambhuwala, Paonta Road, Distt. Sirmour (H.P.) -
173001
pH
DCA,
Vijayawada
, Andhra Pradesh
Central Drugs Laboratory, Kolkata
21
Paracetamol Tablets IP 500 mg (Pyricool 500)
23444042
11/2023
10/2026
Alkem Health Science, A unit of Alkem Laboratories Limited, Unit - 2,
Samardung, Karek
Dissolution
CDSCO,
East Zone, Kolkata
Central Drugs Laboratory, Kolkata
Block, P.O. Namthan, Dist. Namchi, Sikkim -
737137
22
Ciprofloxacin Hydrochloride Tablets IP 500 mg
2331044
07/2023
06/2026
Aurio Pharma Laboratories Pvt. Ltd., 26/1/1, S.H.K.B
Sarani (Jawpur Road), Dumdum,
Kolkata- 700 074
Dissolution
CDSCO,
East Zone, Kolkata
Central Drugs Laboratory, Kolkata
23
Oseltamivir Oral Suspension I.P. 12 mg
URDP1153
05/2023
10/2024
Unicure India Ltd., Plot No. 46(B) / 49B,
Vill. Raipur, Bhagwanpur, Roorkee, Distt.
Haridwar, Uttarakhand
Description
CDSCO,
East Zone, Kolkata
Central Drugs Laboratory, Kolkata
24
Ambroxol,Guaiphenes in & Terbutaline Syrup (Bromex Expectorant)
BXE064
01/09/2023
31/05/2026
Hygeia Pharmaceuticals MFG (P) Ltd., 608,
Dwarir Road, Dhamaitala Dakshin Jagaddal, Pin - 700
151
Assay of Ambroxol Hydrochloride and Terbutaline Sulphate
CDSCO,
East Zone, Kolkata
Central Drugs Laboratory, Kolkata
25
Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate, Sodium Citrate and Menthol
Syrup (SUNGESIC-C)
002
01/09/2023
31/08/2025
Sunny Industries Private Limited, 23/3/1B, R.N.
Nandan Lane, Kolkata 700 025
Description & Assay of Paracetamol
CDSCO,
East Zone, Kolkata
Central Drugs Laboratory, Kolkata
26
Deferasirox
82231480
02/07/2023
01/07/2027
Glenmark Lifesciences Ltd., Plot No. Z-103/I, Sez Phase II, Dahej, Dist.
Bharuch - 392130, Gujarat, India.
4 Hydrazino benzoic acid
CDSCO,
Ahmedabad
Central Drugs Laboratory, Kolkata
27
Miconazole Nitrate and Fluocinolone Acetonide Ointment (Zole - F)
SXE1800A
08/2023
07/2026
Sun Pharmaceuticals Ind. Ltd., Kh. No. 1335-1340, Near
EPIP- I, Vill- Bhatoli
Kalan, Baddi, Distt. Solan, H.P. 173205
Assay
CDSCO,
Ahmedabad
Central Drugs Laboratory, Kolkata
28
Trihexyphenidyl Hydrochloride Tablets IP 2 mg (Ridyl)
AR-132
06/2023
05/2025
Apex Formulations Pvt. Ltd., 1276,
Rajpur, Ahmedabad- Mehsana Highway, Dist. Mehsana,
Gujarat.
Assay
CDSCO,
Ahmedabad
Central Drugs Laboratory, Kolkata
29
Levosalbutamol Sulphate, Ambroxol Hydrochloride, Guaiphenesin and Menthol Syrup 60 ml Syrup (HISTARED- LS)
L23K015
11/2023
10/2025
Fanal Pharmaceuticals LLP, 67, Surbhi Radhe Industrial Zone, Survey No. 251, At. Khambha,
360311, Gujarat, India
Description & Assay of Levosalbutamol
CDSCO,
Ahmedabad
Central Drugs Laboratory, Kolkata
30
TERBUTALINE SULPHATE, BROMHEXINE HCl & GUAIPHENESIN SYRUP (NEFDYL-X)
WHL-01715
Nov-2023
Oct-2025
Warner Hindusthan Pvt. Ltd.,. 24-85/7, Sy.No.548 & 551,
Laxmi Narayana Nagar Colony, New
IDA, Uppal, Hyderabad-39 (TS)
Assay of Bromhexine Hydrochloride
CDSCO
Hyderabad
CDTL,
Hyderabad
31
BROMHEXINE HYDROCHLORIDE
SYRUP 4mg/5ml
31413
01-Aug-
2023
31-Jul-2025
Zenith Drugs Pvt.
Ltd., 72/5, Muradpura (Orangpura) Dhar Road, Near Kalaria, Indore 453001 (MP) India
pH and Assay
CDSCO,
Sub Zone, Indore
CDTL,
Hyderabad
32
POVIDONE-IODINE SOLUTION BP (VIDON)
EVO310
01-Jun-
2023
31-May-
2026
US PHARMA (I) PVT.LTD
Plot No. 4, Gut No. 66, H.No. 827-830,
Khupi Village, Near Kudus, Tal. Wada, Dist. Palghar, 421312, Maharashtra,
India.
pH
CDSCO,
West Zone, Mumbai
CDTL,
Hyderabad
33
Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine
Maleate Syrup (Zist- D)
HRL-070
Oct-23
Sep-25
Household Remedies Pvt. Ltd., Plot No.6/35, Dewan And Sons Aliyali,
Palghar- 401 404.
Microbial Limit test
CDSCO,
West Zone, Mumbai
CDTL,
Mumbai
34
Pantoprazole Gastro- resistant Tablets IP (Pantojohn - 20)
T-2210131
Oct-22
Sep-25
Johnlee Pharmaceuticals Pvt Ltd., By Aagya Biotech Pvt. Ltd., 1.5, Manglour- saharanpur road, Manglour- 247656,
Roorkee, Haridwar.
Dissolution in buffer stage
CDSCO,
West Zone, Mumbai
CDTL,
Mumbai
35
Atorvastatin and Clopidogrel Capsules (10mg/75mg)
MC221173
Dec-2022
Nov-2024
Mascot Health Series Pvt. Lt., Plot No. 79,80,Sector-6A, IIE,
Sidcul, Haridwar- 249403
Dissolution of Atorvastatin Calcium calculated as Atorvastatin
CDSCO,
North Zone Ghaziabad
RDTL,
Chandigarh
36
Moxonidine Tablets BP (0.3 mg)
MXDY0005
Jun-2022
May-2025
MICRO LABS LIMITED UNIT-III, R.S.No. 63/ 3 & 4,
Thiruvander Koil, Puducherry-605102
Dissolution
CDSCO,
North Zone Ghaziabad
RDTL,
Chandigarh
37
Calcium Carbonate, Vitamin D3 and L- Lysine Suspension (Oscaid Suspension)
RL22070
Aug-2022
Jul-2024
RACHIL PHARMA.., 18-19,
Phase-1, Ind.Area, Sansarpur Terrace, Distt : Kangra (HP)-
176501
Description, Identification and Assay of Vitamin D3
O/o CMO Bilaspur District- Bilaspur H.P.-
174001
RDTL,
Chandigarh
38
Cefodoxime Proxetil and Potassium Clavulanate Tablets
MBT-22012
Jun-2022
Sep-2023
Magnatek Enterprises, Plot No. 74 C (II) HPSIDC
Ind. Area Baddi, Distt. Solan (H.P.) 1732025
Assay of Potassium Clavulanate Diluted calculated as Clavulanic Acid
O/o State Drugs Controller,
H.Q. Baddi, Distt.
Solan, HP- 173205
RDTL,
Chandigarh
39
Ofloxacin and Ornidazole Tablets IP (Normal -OZ TABLETS)
122257
Dec-2022
Nov-2024
Biologics Inc., Suketi Road, Kala-Amb, Distt. Sirmour (H.P.)- 173030
Dissolution of Ofloxacin and Ornidazole
State FDA Qatilgah Kargil- 194103 (UT
Ladakh)
RDTL,
Chandigarh
40
Cefuroxime Axetil Tablets IP 500 mg
JAK-20
May-2023
Arp-2025
Agron Remedies Pvt. Ltd., Sarverkhera, Moradabad Road, Kashipur-244713
(Uttarakhand)
Dissolution and Assay of Cefuroxime Axetil calculated as Cefuroxime
CDSCO
Sub-Zone, Jammu
RDTL,
Chandigarh
41
Ambroxol, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup (Tricodex A Syrup)
SRLK230054
Nov-2023
Oct-2025
SYSTOLE REMEDIES PVT.
LTD. Vill. Ogli, Kala Amb, Teh. Nahan, Distt. Sirmour (H.P.)-
173030
Assay of Terbutaline Sulphate
CDSCO ,
Baddi
RDTL,
Chandigarh
42
Ambroxol hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup
(Bronter SYRUP)
NARL-0038
Nov-2023
Oct-2025
M Sea Pharmaceuticals (P) Ltd., Surajpur, Paonta Sahib, Sirmour Himachal
Pradesh-173001
Assay of Menthol
CDSCO ,
Baddi
RDTL,
Chandigarh
43
Ambroxol Hydrochloride, Levosalbutamol and Guaiphenesin Syrup (Saivent-LX Syrup)
MAG-S-1972
Oct-2023
Sep-2025
Magma Allianz Laboratories Ltd., Vill. Guruwala, P.O. Bhagani Sahib, Teh. Paonta Sahib, Distt.
Sirmour (H.P.)- 173025
Assay of Ambroxol Hydrochloride and Levosalbutamol Sulphate calculated as Levosalbutamol
CDSCO
Baddi
RDTL,
Chandigarh
44
Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup (KOFVON LS Syrup)
OL-032309
Mar-2023
Feb-2025
Sickcure Pharmaceuticals, Plot No. 52A, Industiral Area, Gondpur, Tehsil-Paonta Sahib, Distt. Sirmour (H.P.)
173025
Ethylene Glycol (EG) is exceeding the permissible limit
CDSCO
Baddi
RDTL,
Chandigarh
45
Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup (AVTUS-TG SYRUP)
BL-36
Jul-2023
Jun-2025
Boffin Biotech Pvt. Ltd., Vill. Behral, Paonta Sahib, Distt. Sirmour-173025 (H.P.)
Assay of Menthol
CDSCO
Baddi
RDTL,
Chandigarh
46
Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride Syrup
(Expotus-D Syrup)
LSF-B0075
Apr-2023
Mar-2025
Spen Formulations Pvt. Ltd., Plot No- 123, Industrial Area, Mehatpur, Distt.
UNA-174315 (H.P.)
Assay of Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine
Hydrochloride
CDSCO
Baddi
RDTL,
Chandigarh
47
Dextromethorphan Hyhdrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup
(ROYCOF-DX SYRUP)
GL2301001
Jan-2023
Dec-2024
Roseate Medicare, Village Anji, PO Barog, Distt. Solan, 173211 (H.P.) INDIA
Identification and Assay of Chlorpheniramine Maleate and Assay of Dextromethorphan Hydrobromide
CDSCO
Baddi
RDTL,
Chandigarh
48
Terbutaline Sulphate, Guaiphenesin, Ambroxol Hydrochloride and Menthol Syrup (Xpert- S Syrup)
6530
Feb-2023
Jan-2025
ESTRA PHARMACEUTICA
LS, Fatehgarh Churian Road, Amritsar Br.
Assay of Ambroxol Hydrochloride and Menthol
CDSCO
Baddi
RDTL,
Chandigarh
49
LEVOCETIRIZINE HYDROCHLORIDE & MONTELUKAST SODIUM TABLETS
I.P. (Cetliv-M)
MDHMT-436
Mar-2023
Feb-2025
M Sea Pharmaceuticals (P) Ltd. (A GMP ISO 9001: 2015 CERTIFIED CO.,
Surajpur, Paonta Sahib, Sirmour
(H.P.)- 173001
Dissolution of Montelukast
Assistant Director (Food & Drugs) Mizoram
RDTL,
Guwahati
50
Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP
23112703
Mar-2023
Feb-2025
MERCURY LABORATORIES LIMITED., Unit
No.2, Halol Baroda Road, Village: Jarod. Tal: Waghodia, Dist:
Vadodara- 391510
Dissolution of Montelukast
Inspector of Drugs, Assam
RDTL,
Guwahati
51
DICLOFENAC SODIUM INJECTION I.P.
75mg/3ml
I213109
Jul-2023
Jun-2025
ANG Lifesciences India Ltd., Village Malkumajra, Nalagarh Road, Baddi, Distt. Solan- 173205 (H.P.)
Description
Inspector of Drugs, Assam
RDTL,
Guwahati
52
Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (Montas- L)
MAT22030
Jun-2022
May-2024
Tirupati Medicare Limited, Nahan Road, Paonta Sahib, Dist. Sirmour, Himachal Pradesh -
173 025, India.
Dissolution of Montelukast
Inspector of Drugs, Sikkim
RDTL,
Guwahati
53
Pheniramine Maleate Tablet I.P. (APVIL)
RT220422
May-2022
Apr-2025
Ridley Life Science Pvt. Ltd.,, D-1651, DSIDC, Indl.
Complex, Narela, Delhi- 110040
Description
Inspector of Drugs, Assam
RDTL,
Guwahati
54
Pheniramine Maleate Tablet IP (APVIL)
RT220512
Jun-2022
May-2025
RIDLEY LIFE SCIENCE PVT. LTD., D-1651, DSIDC Indl.
Complex, Narela, Delhi-110040
Description
Inspector of Drugs, Assam
RDTL,
Guwahati
55
Levocetirizine Hydrochloride & Montelukast Sodium
IP Tablets (Raremont- LC)
TSF-B1689
Apr-2023
Mar-2025
Spen Formulations Pvt. Ltd., Plot No- 123, Industrial Area, Mehatpur, Distt.
UNA- 174315 (H.P.)
Dissolution and Assay of Montelukast
Inspector of Drugs, Assam
RDTL,
Guwahati
56
Serratiopeptidase Tablets IP 10 mg (Serrarid-10)
RT220358
Apr-2022
Mar-2024
RIDLEY LIFE SCIENCE PVT. LTD, D-1651, DSIDC, Indl.
Complex, Narela, Delhi-110040
Disintegration & Description
Inspector of Drugs, Meghalaya
RDTL,
Guwahati
S.No
Name of Drugs/medical device/cosmetics
Batch No.
Date of Manuf
acture
Date of Expiry
Manufacture d By
Reason for failure
Drawn By (From state/CDS
CO Zone)
From (Name of Laboratory)
Remarks
57
Telmisartan Tablets 40 mg and Amlodipine 5 mg Tablets IP (Telma AM)
05230355
03/202
3
02/2026
Glenmark Pharmaceutica ls Ltd., Village Kishanpura, Baddi- Nalagarh Road, Tehsil Baddi, Distt. Solan (H.P.)
Assay & Dissolution of Telmisartan & Amlodipine
CDSCO,
North Zone
Central Drugs Laboratory, Kolkata
The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is
subject to outcome of further investigation.
58
Telmisartan Tablets I.P. 40 mg (Telma 40)
I8220890
12/202
2
11/2025
Glenmark Pharmaceutica ls Ltd., Samlik Marchak, Industrial Growth Centre, East Sikkim, Sikkim - 737135
Dissolution
CDSCO,
North Zone
Central Drugs Laboratory, Kolkata
The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of
further investigation.
Also Read: AstraZeneca India bags dual CDSCO nod for Trastuzumab deruxtecan
To view the official notice, click the link below:
https://medicaldialogues.in/pdf_upload/feb2024-alert-235330.pdf
1 year 2 months ago
News,Industry,Pharma News,Top Industry News
Puerto Rico declares an emergency as cases of dengue fever spike - Raw Story
- Puerto Rico declares an emergency as cases of dengue fever spike Raw Story
- Puerto Rico Declares Epidemic Over Dengue - Videos from The Weather Channel The Weather Channel
- Dengue Fever: Puerto Rico Declares Emergency After Viral Cases Spike Healthline
- Dengue and severe dengue World Health Organization (WHO)
- Dengue fever outbreak in Puerto Rico creates public health emergency NBC News
1 year 2 months ago
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Karnataka doctor loses Rs 16.5 lakh to fraudster posing as Delhi Police official
Puttur: In a distressing incident, a 69-year-old doctor was duped of Rs 16.5 lakh after online fraudsters threatened him with immediate arrest for narcotics and other illicit financial activities. The culprit introduced himself as a police officer from Delhi and informed the doctor that there was an active arrest warrant issued against him.
The senior doctor has been identified as a resident of Bolvaru, Kasaba village. As per the details furnished in the complaint lodged by the doctor, the ordeal commenced on the morning of March 28 when he received an unexpected call from an unfamiliar individual who identified himself as a police officer stationed in Delhi.
Also Read:Doctor duped of Rs 67,500 on pretext of booking hotel room for holiday
As per a recent media report by Daijiworld, the caller, claiming authority, apprised him of a purported case registered against him in the capital city, implicating him in offences involving narcotics, illicit financial activities, and human trafficking. Shockingly, the caller disclosed the existence of an active arrest warrant against him.
Exploiting the urgency of the situation, the caller coerced the doctor into believing that he needed to promptly address the matter by either appearing at the CBI court in Delhi or by handling the proceedings online. To ensure compliance, the fraudster directed him to transfer a substantial sum of money to a designated bank account, assuring him of its eventual reimbursement after the resolution of the case. Additionally, the caller issued thinly veiled threats of imminent arrest by the Delhi police should the doctor adhere to the prescribed instructions. In an attempt to authenticate the gravity of the situation, the fraudster cunningly forwarded fabricated documents via WhatsApp, displaying the doctor's name and personal details. Afraid of getting implicated legally, the victim fearing for his liberty, acquiesced to the demands and initiated an RTGS transfer of Rs 16.5 lakh to the provided bank account, reports The Daily. However, the ordeal did not conclude there. In a bold move, the scammer brazenly demanded further monetary transactions, prompting him to harbour suspicions regarding the legitimacy of the situation. Recognizing the urgency of the matter and the duplicitous nature of the caller, he promptly reported the distressing incident to the authorities at the Puttur City police station, seeking redress and justice. In response to his complaint, a formal case has been registered, and investigations into the fraudulent activities are currently underway. Also Read: UP doctor duped of Rs 40 lakh in digital arrest scam
1 year 2 months ago
State News,News,Health news,Karnataka,Doctor News,Latest Health News,Recent Health News
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Artificial Intelligence tool successfully predicts ventricular arrhythmia from standard heart tracings: Study
In a Leicester study that looked at whether artificial intelligence (AI) can be used to predict whether a person was at risk of a lethal heart rhythm, an AI tool correctly identified the condition 80 per cent of the time.
The findings of the study, led by Dr Joseph Barker working with Professor Andre Ng, Professor of Cardiac Electrophysiology and Head of Department of Cardiovascular Sciences at the University of Leicester and Consultant Cardiologist at the University Hospitals of Leicester NHS Trust, have been published in the European Heart Journal-Digital Health.
Ventricular arrhythmia (VA) is a heart rhythm disturbance originating from the bottom chambers (ventricles) where the heart beats so fast that blood pressure drops which can rapidly lead to loss of consciousness and sudden death if not treated immediately.
NIHR Academic Clinical Fellow Dr Joseph Barker co-ordinated the multicentre study at the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre, and co-developed an AI tool with Dr Xin Li, Lecturer in Biomedical Engineering, School of Engineering. The tool examined Holter electrocardiograms (ECGs) of 270 adults taken during their normal daily routine at home.
These adults had the Holter ECGs taken as part of their NHS care between 2014 and 2022. Outcomes for these patients were known, and 159 had sadly experienced lethal ventricular arrhythmias, on average 1.6 years following the ECG.
The AI tool, VA-ResNet-50, was used to retrospectively examine ‘normal for patient’ heart rhythms to see if their heart was capable of the lethal arrythmias.
Professor Ng said: “Current clinical guidelines that help us to decide which patients are most at risk of going on to experience ventricular arrhythmia, and who would most benefit from the life-saving treatment with an implantable cardioverter defibrillator are insufficiently accurate, leading to a significant number of deaths from the condition.
“Ventricular arrhythmia is rare relative to the population it can affect, and in this study we collated the largest Holter ECG dataset associated with longer term VA outcomes.
“We found the AI tool performed well compared with current medical guidelines, and correctly predicted which patient’s heart was capable of ventricular arrhythmia in 4 out of every 5 cases.
“If the tool said a person was at risk, the risk of lethal event was three times higher than normal adults.
“These findings suggest that using artificial intelligence to look at patients’ electrocardiograms while in normal cardiac rhythm offers a novel lens through which we can determine their risk, and suggest appropriate treatment; ultimately saving lives.”
He added: “This is important work, which wouldn’t have been possible without an exceptional team in Dr Barker and Dr Xin Li, and their belief and dedication to novel methods of analysis of historically disregarded data.”
Reference:
Joseph Barker, Xin Li, Ahmed Kotb, Akash Mavilakandy, Ibrahim Antoun, Chokanan Thaitirarot, Ivelin Koev, Sharon Man, Fernando S Schlindwein, Harshil Dhutia, Shui Hao Chin, Ivan Tyukin, William B Nicolson, G Andre Ng, Artificial intelligence for ventricular arrhythmia capability using ambulatory electrocardiograms, European Heart Journal - Digital Health, 2024;, ztae004, https://doi.org/10.1093/ehjdh/ztae004
.
1 year 2 months ago
Cardiology-CTVS,Cardiology & CTVS News,Top Medical News,Latest Medical News
Health Archives - Barbados Today
Fogging schedule for April 2 – 5
The Vector Control Unit of the Ministry of Health and Wellness will continue its mosquito eradication efforts in the parish of St Michael, this week.
The Unit will visit Field Road, Factory Avenue, Parkinson Field, Rock Avenue, Rock Close, Wildey Road, Wildey Garden, Terrace Road, East Terrace Avenues Nos 1 to 3, Newton Crescent, St Ann’s Road, and neighbouring districts on Tuesday, April 2.
The following day, Wednesday, April 3, Villa Road, Valerie Housing Area, Collymore Rock Main Road, McClean Gap, Brittons Cross Road, Mission Gap, Layne’s Road, Perkins Road, Seaman Road, Millyard Road, Knights Road, and Scotts Gap will be sprayed.
On Thursday, April 4, the team will go to Villa Road, Warner Road, Liverpool Road, Reece Road, London Road, Burkes Road, and surrounding communities.
The fogging exercise for the week will conclude on Friday, April 5, in Reece Road Nos 1 to 3, Flag Staff, Streats Road (both sides), Ifill Road (both sides), and Highgate Gardens.
Fogging takes place from 4:30 to 8:30 p.m. daily. Householders are reminded to open their windows and doors to allow the spray to enter. Children should not be allowed to play in the spray.
Members of the public are advised that the completion of scheduled fogging activities may be affected by events beyond the Unit’s control. In such circumstances, the Unit will return to communities affected in the soonest possible time.
The post Fogging schedule for April 2 – 5 appeared first on Barbados Today.
1 year 2 months ago
Health, Local News, Alerts
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Vacancies For Assistant Professor: Walk In Interview At RML Hospital Delhi, View All Details Here
New Delhi: The Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital (ABVIMS and RML Hospital Delhi), has announced the vacancies for the post of Assistant Professor on a contract basis in this medical institute.
Dr Ram Manohar Lohia Hospital, formerly known as Willingdon Hospital, was established by the British for their staff and had only 54 beds. After independence, its control was shifted to New Delhi Municipal Committee. In 1954, its control was again transferred to the Central Government of Independent India.
RML Hospital Vacancy Details:
Total no of vacancies: 02
The Vacancies are in the Department of Neurology and Gastroenterology.
The date of Walk-In-Interview - 3rd April 2024.
Venue and Reporting Time:- Room No. 104, 1st Floor, Administrative Block, ABVIMS by 9.30 a.m.
For more details about Qualifications, Age, Pay Allowance, and much more, click on the given link:https://medicaljob.in/jobs.php?post_type=&job_tags=RML+Hospital&location=&job_sector=all
Eligible Candidates (How to Apply)?
1. Suitable and willing candidate may report in Room No. 104, 1st Floor, Administrative Block, ABVIMS for walk-in-interview by 9.30 a.m. on the aforesaid dates along with duly filled in application form (2 copies of Annexure-I). 4 passport size photographs, original and two set of photocopies (All listed documents in application form of Annexure-I) of relevant documents. No TA/DA is admissible for attending the interview.
2. The candidate who is already in Govt. Service shall submit No Objection Certificate from the present employer at the time of Interview.
3. No TA/DA is admissible for the interview. Canvassing of any kind will lead to disqualification Suitable and willing candidates may walk in for interview on the date specified for the interview of the particular specialty along with application in prescribed format along with 4 passport size photographs. Candidates should report in the Room No, 104, 1st Floor. Administrative Block. ABVIMS by 9 30 a.m. on the aforesaid dates The candidates must bring the filled application form (as per Annexure-II) and the original certificates at the time of registration (with two set of self attested copies of all documents)
4. Jurisdiction of Dispute. In case of any legal dispute the jurisdiction of court will be Delhi/New Delhi only The Competent Authority reserves the right of any amendment, cancellation and changes to this advertisement as a whole or in part without assigning any reason
Also Read:Specialist Post Vacancies At ESIC Hospital Gujarat In Various Dept, Apply Now
1 year 2 months ago
Jobs,State News,News,Health news,Delhi,Medical Jobs,Hospital & Diagnostics,Doctor News,Latest Health News,Recent Health News